Cancer Statistics by Gender

Cancer Statistics by Gender

Global Cancer Incidence by Type and Gender (2022 Estimates)

Age-standardized rates per 100,000 people (GLOBOCAN 2022)

Cancer Type	Male Incidence	Female Incidence	Most Affected Gender	Notes
Lung	34.3	13.5	♂ Male	Leading cause of cancer death in men
Breast	0.5	47.8	♀ Female	Most diagnosed cancer in women
Prostate	29.3	-	♂ Male	2nd most common in men globally
Colorectal	20.6	14.3	♂ Male	Slightly higher in men
Stomach	15.8	9.5	♂ Male	More common in men
Liver	14.3	5.2	♂ Male	Linked to hepatitis/alcohol
Cervical	-	13.3	♀ Female	Only affects women
Thyroid	3.1	10.1	♀ Female	3x more common in women

5-Year Survival Rates by Gender (U.S. Data, 2013-2019)

Cancer Type	Male Survival	Female Survival	Gender Gap	Notes
Thyroid	96%	98%	+2% (♀ higher)	Excellent survival for both
Lung	19%	25%	+6% (♀ higher)	Women often diagnosed earlier
Colorectal	63%	65%	+2% (♀ higher)	Women may seek care sooner
Bladder	77%	76%	-1% (♂ higher)	Men more likely to get it
Liver	20%	18%	-2% (♂ higher)	Men have higher incidence
Breast	-	91%	N/A	Male breast cancer survival: ~84%
Prostate	97%	-	N/A	Highly treatable if detected early

Key Takeaways

Men have higher cancer incidence and mortality overall, especially for lung, liver, and bladder cancers.
Women generally have better survival rates for most shared cancers (e.g., lung, colorectal).
Biological and behavioral factors (hormones, screening participation, smoking rates) contribute to gender differences.
Gender-specific cancers (prostate, breast, cervical) require targeted prevention strategies.

Sources: GLOBOCAN 2022, American Cancer Society (2024), SEER Program (U.S. survival data)

© kidney disease clinic.